UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z
Number of items: 296.

A

Aitchison, KL; Rahim, AA; Hughes, D; Kinnon, C; Waddington, SN; Howe, SJ; (2012) Developing lentiviral vectors for gene therapy of Type I Gaucher Disease. Presented at: Annual Conference of the British-Society-for-Gene-Therapy (BSGT), UCL Inst Child Hlth, London, ENGLAND.

Al-Thihli, K; Ebrahim, H; Hughes, DA; Patel, M; Tipple, M; Salvarinova, R; Gardiner, J; ... Waters, PJ; + view all (2012) A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy. GENE , 497 (2) pp. 320-322. 10.1016/j.gene.2012.01.056.

Ali, S; Sergeant, R; O'Brien, SG; Foroni, L; Hedgley, C; Gerrard, G; Milojkovic, D; ... Rezvani, K; + view all (2012) Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia. BLOOD , 120 (3) pp. 697-698. 10.1182/blood-2012-04-421016.

Allen, CG; Tinsley, SP; Hills, RK; Evans, CM; Lamb, K; Sellar, RS; Sale, M; ... Gale, RE; + view all (2012) The impact of mutant level on clinical outcome in acute myeloid leukaemia differs according to the mutated gene. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 20). WILEY-BLACKWELL

Arkenau, H-T; Saggese, M; Lemech, C; (2012) Advanced gastric cancer: Is there enough evidence to call second-line therapy standard? WORLD JOURNAL OF GASTROENTEROLOGY , 18 (44) pp. 6376-6378. 10.3748/wjg.v18.i44.6376. Gold open access

Arkenau, H-T; Saggese, M; Lemech, C; (2012) DABRAFENIB MESYLATE Serine/Threonine-Protein Kinase B-raf Inhibitor, Oncolytic. DRUGS OF THE FUTURE , 37 (7) pp. 469-474. 10.1358/dof.2012.37.7.1820872.

Armstrong, CA; Jones, GD; Anderson, R; Iyer, P; Narayanan, D; Sandhu, J; Singh, R; ... Tufarelli, C; + view all (2012) DNMTs are required for delayed genome instability caused by radiation. Epigenetics , 7 (8) pp. 892-902. 10.4161/epi.21094.

Arrieta Bolanos, ER; Madrigal, J; Shaw, B; (2012) Functional consequences of TGFB1 polymorphisms in regulatory T cells and haematopoietic stem cell transplantation. Presented at: The Joint 16th International HLA and Immunogenetics Conference/26th European Immunogenetics and Histocompatibility Conference/23rd British Society of Histocompatibilty and Immunogenetics Conference, Liverpool, UK. Green open access
file

Arrieta Bolanos, ER; Madrigal, JA; Shaw, BE; (2012) Human Leukocyte Antigen Profiles of Latin American Populations: Differential Admixture and Its Potential Impact on Hematopoietic Stem Cell Transplantation. Bone Marrow Research , 2012 , Article 136087. 10.1155/2012/136087. Green open access
file

Arrieta Bolanos, ER; Madrigal, JA; Shaw, BE; Marsh, SGE; Salazar-Sánchez, L; (2012) The frequency of HLA-B*57:01 and the risk of Abacavir hypersensitivity reactions in the Costa Rica Central Valley Population. Presented at: The Joint 16th International HLA and Immunogenetics Conference/26th European Immunogenetics and Histocompatibility Conference/23rd British Society of Histocompatibilty and Immunogenetics Conference, Liverpool, UK. Green open access
file

Arrieta-Bolanos, E; Madrigal, JA; Shaw, BE; (2012) FUNCTIONAL CONSEQUENCES OF TGFB1 POLYMORPHISMS IN REGULATORY T CELLS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION. Presented at: Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, ENGLAND. Green open access
file

Arrieta-Bolanos, E; Madrigal, JA; Shaw, BE; (2012) Transforming growth factor-ss 1 polymorphisms and the outcome of hematopoietic stem cell transplantation. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 192-202. 10.1111/j.1744-313X.2012.01089.x.

Arrieta-Bolaños, E; Madrigal, JA; Shaw, BE; (2012) Transforming growth factor-β1 polymorphisms and the outcome of hematopoietic stem cell transplantation. Int J Immunogenet , 39 (3) pp. 192-202. 10.1111/j.1744-313X.2012.01089.x.

Artim-Esen, B; Pericleous, C; Mackie, I; Ioannou, Y; Rahman, A; Isenberg, DA; Giles, I; (2012) ANTI-Factor Xa Antibodies ARE Significantly Increased in Patients with Systemic LUPUS Erythematosus and Antiphospholipid Syndrome. In: (Proceedings) Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP). (pp. S739-S739). WILEY-BLACKWELL

Aslan, D; Akata, RF; Holme, H; Vulliamy, T; Dokal, I; (2012) Limbal stem cell deficiency in patients with inherited stem cell disorder of dyskeratosis congenita. Int Ophthalmol , 32 (6) pp. 615-622. 10.1007/s10792-012-9611-8.

B

BENJAMIN, R; (2012) Antiangiogenic strategies for the treatment of haematological malignancies. Doctoral thesis , UCL (University College London). Green open access
file

Banerji, U; van Doorn, L; Papadatos-Pastos, D; Kristeleit, R; Debnam, P; Tall, M; Stewart, A; ... Eskens, FA; + view all (2012) A phase I pharmacokinetic and pharmacodynamic study of CHR-3996, an oral class I selective histone deacetylase inhibitor in refractory solid tumors. Clin Cancer Res , 18 (9) pp. 2687-2694. 10.1158/1078-0432.CCR-11-3165.

Bates, AW; (2012) Diagnosing eosinophilic colitis: histopathological pattern or nosological entity? Scientifica , 2012 , Article 682576. 10.6064/2012/682576. Green open access
file

Bates, AW; Ram, M; (2012) Fibro-osteochondroma of the uterus. Indian Journal of Pathology and Microbiology , 55 (4) 555 - 556. 10.4103/0377-4929.107814. Green open access
file

Beck, S; Bernstein, BE; Campbell, RM; Costello, JF; Dhanak, D; Ecker, JR; Greally, JM; ... Jones, PA; + view all (2012) A Blueprint for an International Cancer Epigenome Consortium. A Report from the AACR Cancer Epigenome Task Force. CANCER RESEARCH , 72 (24) pp. 6319-6324. 10.1158/0008-5472.CAN-12-3658.

Bell, CG; (2012) Epigenetics in Human Disease. In: Tollefsbol, T, (ed.) Epigenetics in Human Disease. Academic Press

Benjamin, ER; Brignol, N; Young, B; Chang, HH; Khanna, R; Soska, R; Sitaraman, SA; ... Valenzano, KJ; + view all (2012) MIGALASTAT HCL REDUCES GLOBOTRIAOSYLSPHINGOSINE (LYSO-GB3) IN PLASMA OF FABRY PATIENTS AND IN TISSUES OF FABRY TRANSGENIC MICE. Presented at: UNSPECIFIED.

Bez, C.; (2012) The role of the telomere bouquet in controlling spindle pole body composition in fission yeast meiosis. Doctoral thesis , UCL (University College London). Green open access
file

Bhosle, J.; (2012) Modulation of DNA strand break induction and repair by tyrosine kinase inhibitors targeted against EGFR and HER2. Doctoral thesis , UCL (University College London). Green open access
file

Bolton-Maggs, PHB; Chapman, C; Mistry, H; Williamson, L; Cohen, H; (2012) Continued absence of transfusion-associated graft versus host disease despite failures to provide irradiated products to patients at risk - more than a decade of data from SHOT. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 3-4). WILEY-BLACKWELL

Bolton-Maggs, PHB; Cohen, H; (2012) Serious hazards of transfusion haemovigilance - The UK experience. European Oncology and Haematology , 8 (2) pp. 127-129.

Bolton-Maggs, PHB; Davies, T; Poles, D; Ball, J; Cohen, H; (2012) Errors in administration of anti-D immunoglobulin to prevent RhD haemolytic disease of the fetus and newborn: mothers and babies put at risk. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 79). WILEY-BLACKWELL

Borroni, R; Grassi, S; Concardi, M; Puccio, I; Arbustini, E; (2012) Immunohistochemical study of dermal microvasculature density and vessel basement membrane thickness in Bateman's senile purpura. Journal of Investigative Dermatology 10.1038/jid.2012.294.

Brown, N.J.; (2012) Characterisation of the centrosome protein Cep63. Doctoral thesis , UCL (University College London). Green open access
file

Bruno, S; Tu, VL; Grillo, F; Isgro, G; Tsochatzis, E; Hall, AR; Dhillon, AP; (2012) Liver collagen proportionate area and septal thickness/nodule size: a comparison for predicting decompensation in cirrhosis. In: (Proceedings) 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). (pp. 932A-933A). WILEY-BLACKWELL

Butt, MA; Haidry, RJ; Oukrif, D; Dunn, JM; Gupta, A; Bhatt, M; Hrynkiewicz, L; ... Novelli, MR; + view all (2012) POLO-LIKE KINASE 1 EXPRESSION PREDICTS ANEUPLOIDY IN THE BARRETT'S METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE. In: (pp. A302-A302). B M J PUBLISHING GROUP

Butt, MA; Haidry, RJ; Oukrif, D; Dunn, JM; Gupta, A; Bhatt, M; Waheed, AH; ... Novelli, M; + view all (2012) Polo-Like Kinase 1 Expression Predicts Aneuploidy in the Barrett's Metaplasia-Dysplasia-Carcinoma Sequence. In: (Proceedings) Digestive Disease Week (DDW). (pp. S525-S525). W B SAUNDERS CO-ELSEVIER INC

Butt, MA; Haidry, RJ; Oukrif, D; Pye, H; Stamati, I; Yahioglu, G; Rodriguez-Justo, M; ... Lovat, LB; + view all (2012) HER2 EXPRESSION IN THE BARRETT'S METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE AND POTENTIAL TARGETING IN VITRO WITH THE SINGLE CHAIN ANTIBODY FRAGMENT C6.5. In: (pp. A302-A303). B M J PUBLISHING GROUP

Butt, MA; Haidry, RJ; Oukrif, D; Pye, H; Stamati, I; Yahioglu, G; Rodriguez-Justo, M; ... Lovat, L; + view all (2012) HER-2 Expression in the Barrett's Metaplasia-Dysplasia-Carcinoma Sequence and Potential Targeting In-Vitro With the Single Chain Antibody Fragment C6.5. In: (Proceedings) Digestive Disease Week (DDW). (pp. S526-S526). W B SAUNDERS CO-ELSEVIER INC

Butt, MA; Pye, H; Haidry, RJ; Oukrif, D; Deonarain, M; Novelli, M; Lovat, L; (2012) Aberrantly Glycosylated MUC1 as a Potential Therapeutic Target for Barrett's With High Grade Dysplasia and Primary and Metastatic Oesophageal Adenocarcinoma. In: (Proceedings) Digestive Disease Week (DDW). (pp. S526-S526). W B SAUNDERS CO-ELSEVIER INC

Butt, MA; Pye, H; Haidry, RJ; Oukrif, D; Rashid, M; Banks, MR; Deonarain, MP; ... Lovat, LB; + view all (2012) ABERRANTLY GLYCOSYLATED MUC1 AS A POTENTIAL THERAPEUTIC TARGET FOR BARRETT'S WITH HIGH GRADE DYSPLASIA AND PRIMARY AND METASTATIC OESOPHAGEAL ADENOCARCINOMA. In: (pp. A301-A301). B M J PUBLISHING GROUP

Butt, MA; Pye, H; Stamati, I; Yahioglu, G; Haidry, RJ; Oukrif, D; Novelli, MR; ... Lovat, LB; + view all (2012) IN VITRO CHARACTERISATION OF ABERRANTLY GLYCOSYLATED MUC1 BINDING-PS1 PHOTOIMMUNOCONJUGATES FOR OESOPHAGEAL ADENOCARCINOMA TARGETED PHOTODYNAMIC THERAPY IN PRIMARY AND METASTATIC DISEASE. In: (pp. A301-A301). B M J PUBLISHING GROUP

Butt, MA; Stamati, I; Pye, H; Yahioglu, G; Haidry, RJ; Oukrif, D; Novelli, MR; ... Lovat, LB; + view all (2012) SELECTIVE CYTOTOXICITY OF ABERRANTLY GLYCOSYLATED MUC1 BINDING-PS1 PHOTOIMMUNOCONJUGATES FOR OESOPHAGEAL ADENOCARCINOMA TARGETED PHOTODYNAMIC THERAPY IN PRIMARY AND METASTATIC DISEASE. In: (pp. A302-A302). B M J PUBLISHING GROUP

C

Cain, RJ; Vanhaesebroeck, B; Ridley, AJ; (2012) Different PI 3-kinase inhibitors have distinct effects on endothelial permeability and leukocyte transmigration. Int J Biochem Cell Biol , 44 (11) pp. 1929-1936. 10.1016/j.biocel.2012.07.009.

Calabretta, B; Salomoni, P; (2012) Suppression of autophagy by BCR/ABL. Front Biosci (Schol Ed) , 4 pp. 453-460.

Cameron, D; Barrett-Lee, P; Canney, P; Banerji, J; Bartlett, J; Bloomfield, D; Bowden, S; ... Bliss, JM; + view all (2012) The UK TACT2 Trial: comparison of standard vs accelerated epirubicin in patients requiring chemotherapy for early breast cancer (EBC) (CRUK/05/019). In: AMER ASSOC CANCER RESEARCH

Canzonetta, C; Hoischen, A; Giarin, E; Basso, G; Veltman, JA; Nacheva, E; Nizetic, D; (2012) Amplified segment in the 'Down syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2. Br J Haematol , 157 (2) pp. 197-200. 10.1111/j.1365-2141.2011.08985.x.

Carmichael, CL; Metcalf, D; Henley, KJ; Kruse, EA; Di Rago, L; Mifsud, S; Alexander, WS; (2012) Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A , 109 (38) pp. 15437-15442. 10.1073/pnas.1213454109.

Carpenter, B; Ghorashian, S; Nicholson, E; Griffin, JE; Ahmadi, M; Holler, A; Flutter, B; ... Chakraverty, R; + view all (2012) Targeting Therapeutic T Cells to Tumour Niches. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Castleton, A; Ghorani, E; Zhang, C; Dey, A; Patel, B; Rai, L; Ehlam, M; (2012) Mesenchymal Stromal Cells Are Promising Candidates as Delivery Vehicles for Systemic Oncolytic Measles Virotherapy in Models of Acute Lymphoblastic Leukaemia. In: (Proceedings) 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S211-S211). NATURE PUBLISHING GROUP

Cervantes, A; Markman, B; Siena, S; Pericay, C; Aprile, G; Bridgewater, J; Cubillo, A; ... Tabernero, J; + view all (2012) Translational research with RG7160 (GA201) leads to a phase II clinical study in combination with FOLFIRI in 2nd line metastatic colorectal cancer (mCRC). CANCER RESEARCH , 72 10.1158/1538-7445.AM2012-LB-220.

Chakraverty, R; Mackinnon, S; (2012) Allogeneic stem cell transplantation for lymphoma. In: Sweetenham, J and Abraham, J, (eds.) Emerging Cancer Therapeutics. Demos Medical Publishing

Chan, W-C; Ho, M-R; Li, S-C; Tsai, K-W; Lai, C-H; Hsu, C-N; Lin, W-C; (2012) MetaMirClust: Discovery of miRNA cluster patterns using a data-mining approach. Genomics , 100 (3) pp. 141-148. 10.1016/j.ygeno.2012.06.007.

Chen, C; Constantinou, A; Chester, KA; Vyas, B; Canis, K; Haslam, SM; Dell, A; ... Deonarain, MP; + view all (2012) Glycoengineering Approach to Half-Life Extension of Recombinant Biotherapeutics. BIOCONJUGATE CHEMISTRY , 23 (8) pp. 1524-1533. 10.1021/bc200624a.

Chen, P; Tu, X; Akdemir, F; Chew, SK; Rothenfluh, A; Abrams, JM; (2012) Effectors of alcohol-induced cell killing in Drosophila. Cell Death Differ , 19 (10) pp. 1655-1663. 10.1038/cdd.2012.47.

Chervova, O; (2012) The massless Dirac equation from the continuum mechanics and microlocal analysis perspectives. Doctoral thesis , UCL (University College London). Green open access
file

Chervova, O; Vassiliev, D; (2012) Modelling the neutrino in terms of cosserat elasticity. 12th Marcel Grossmann Meeting on Recent Dev. in Theoretical and Experimental General Relativity, Astrophysics and Relativistic Field Theories - Proc. of the MG 2009 Meeting on General Relativity pp. 2398-2400.

Coats, CJ; Paresi, V; Ramos, M; Janagarajan, K; O'Mahony, C; Dawnay, A; Mehta, A; ... Elliott, PM; + view all (2012) Role of serum NT-proBNP measurement in the diagnosis of early cardiac involvement in patients with anderson-fabry disease. Presented at: Congress of the European-Society-of-Cardiology (ESC), Munchen, GERMANY.

Cohen, H; Bolton-Maggs, P; (2012) Breaking records in blood transfusion safety. TRANSFUSION MEDICINE , 22 (4) pp. 241-243. 10.1111/j.1365-3148.2012.01174.x.

Cohen, H; Bolton-Maggs, PHB; Ball, J; Chapman, C; (2012) Too much blood, too quickly: avoiding hazards associated with transfusion-associated circulatory overload (TACO) identified by SHOT reporting. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 17). WILEY-BLACKWELL

Cohen, H; Mackie, IJ; Westwood, JP; Chitolie, A; Liesner, R; Machin, SJ; (2012) Prothrombin/phosphatidyl serine antibodies in patients with antiphospholipid antibodies. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 33-34). WILEY-BLACKWELL

Cohen, H; Williamson, LM; (2012) Setting up a National Hemovigilance System: SHOT. In: Hemovigilance: An Effective Tool for Improving Transfusion Safety. (pp. 168-179).

Cohen, H; Williamson, LM; (2012) SHOT UK: setting up a haemovigilance scheme. In: de Vries, R and Faber, JC and Robillard, P, (eds.) Haemovigilance. Blackwell-Wiley

Corrie, P; Caplin, M; Reed, N; Qain, W; Lao-Sirieix, S-H; Hardy, R; Armstrong, G; ... Meyer, T; + view all (2012) Treatment of advanced neuroendocrine tumors: Results of the UKINETS and NCRI randomized phase II NET01 trial. In: (Proceedings) ASCO Annual Meeting. (pp. 4121-).

Corrie, P; Caplin, M; Reed, N; Qian, W; Lao-Sirieix, S-H; Hardy, R; Armstrong, G; ... Meyer, T; + view all (2012) Treatment of advanced neuroendocrine tumors: Results of the UKINETS and NCRI randomized phase II NET01 trial. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Cox, ST; Madrigal, JA; Saudemont, A; (2012) Three novel allelic variants of the RAET1E/ULBP4 gene in humans. TISSUE ANTIGENS , 80 (4) pp. 390-392. 10.1111/j.1399-0039.2012.01933.x.

D

Damgaard, RB; Nachbur, U; Yabal, M; Wong, WW; Fiil, BK; Kastirr, M; Rieser, E; ... Gyrd-Hansen, M; + view all (2012) The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol Cell , 46 pp. 746-758. 10.1016/j.molcel.2012.04.014.

Dey, A; Zhang, Y; Castleton, A; Patel, B; Ghorani, E; Rai, L; Elham, M; (2012) Polymorphonuclear Neutrophils(PMNs) Are Cytotoxic for Measles Virus (MV)-Infected Tumor Cells Ex-Vivo, but Their Role in MV-Mediated Oncolysis In-Vivo Is Tumor-Type Dependent. In: (Proceedings) 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S271-S271). NATURE PUBLISHING GROUP

Dignan, FL; (2012) Novel strategies for managing graft-versus-host disease. Doctoral thesis , UCL (University College London).

Dignan, FL; Amrolia, P; Clark, A; Cornish, J; Jackson, G; Mahendra, P; Scarisbrick, JJ; ... British Society for Blood and Marrow Transplantation, ; + view all (2012) Diagnosis and management of chronic graft-versus-host disease. Br J Haematol , 158 (1) pp. 46-61. 10.1111/j.1365-2141.2012.09128.x.

Dignan, FL; Clark, A; Amrolia, P; Cornish, J; Jackson, G; Mahendra, P; Scarisbrick, JJ; ... Potter, MN; + view all (2012) Diagnosis and management of acute graft-versus-host disease. British Journal of Haematology

Dignan, FL; Greenblatt, D; Cox, M; Cavenagh, J; Oakervee, H; Apperley, JF; Fielding, AK; ... Scarisbrick, JJ; + view all (2012) Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplantation , 47 (6) pp. 824-830. 10.1038/bmt.2011.186.

Dubois, E; Jacoby, M; Blockmans, M; Pernot, E; Schiffmann, SN; Foukas, LC; Henquin, J-C; ... Schurmans, S; + view all (2012) Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse. CELLULAR SIGNALLING , 24 (11) pp. 1971-1980. 10.1016/j.cellsig.2012.06.012.

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AHV; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. MOLECULAR GENETICS AND METABOLISM , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006. Gold open access

de Gruijl, TD; Ginhoux, F; Bousso, P; Bieber, T; Piguet, V; von Stebut, E; Dudziak, D; (2012) Fondation rene touraine pour la dermatologie. Exp Dermatol , 21 (10) pp. 802-814. 10.1111/exd.12000.

E

El-Sharkawi, D; Ali, A; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2012) ASXL1 mutations are infrequent in young patients with primary acute myeloid leukaemia. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 56). WILEY-BLACKWELL

El-Sharkawi, D; Basu, S; Ocampo, C; Qian, W; D'Sa, S; Hoskin, PJ; Ardeshna, KM; (2012) Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy. Leuk Lymphoma , 53 (10) pp. 1949-1952. 10.3109/10428194.2012.679360.

Enting, D; Ang, JE; O'Hanlon-Brown, C; Kristeleit, RS; Uttenreuther-Fischer, M; Pemberton, K; Pelling, K; ... Spicer, J; + view all (2012) A PHASE I STUDY OF DAILY AFATINIB, AN IRREVERSIBLE ERBB FAMILY BLOCKER, COMBINED WITH WEEKLY PACLITAXEL AND 2-WEEKLY BEVACIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMOURS. Annals of Oncology , 23 (Suppl 9) 10.1093/annonc/mds395.

Enver, T; (2012) Gene Regulatory Networks Governing Hematopoietic Stem Cell Development and Identity. In: AMER SOC CELL BIOLOGY

Erkan, D; Rahman, A; Cohen, H; Machin, SJ; Pierangeli, SS; (2012) What are the potential future treatments in antiphospholipid syndrome? In: Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. (pp. 261-287).

Erturan, G; Holme, H; Cassoni, A; Tirabosco, R; Pollock, R; Briggs, T; Michelagnoli, M; (2012) CAN WE USE THE TORONTO EXTREMITY SALVAGE SCORE TO MEASURE FUNCTIONAL OUTCOME IN PAEDIATRIC DESMOID FIBROMATOSIS? PEDIATRIC BLOOD & CANCER , 59 (6) pp. 1072-1073.

Erturan, G; Holme, H; Iyer, S; (2012) Corynebacterium pseudodiphtheriticum septic arthritis secondary to intra-articular injection--a case report and literature review. J Med Microbiol , 61 (Pt 6) pp. 860-863. 10.1099/jmm.0.037937-0.

Erturan, G; Holme, H; Smith, R; Dodds, R; Iyer, S; (2012) Successful use of daptomycin in Panton-Valentine leucocidin positive Staphylococcus aureus paediatric osteomyelitis. Int J Surg Case Rep , 3 (7) pp. 238-241. 10.1016/j.ijscr.2012.03.014.

F

FOLEY, JH; NESHEIM, ME; RIVARD, GE; BRUMMEL-ZIEDINS, KE; (2012) Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A. Haemophilia , 18 (3) e316-e322. 10.1111/j.1365-2516.2011.02648.x.

Fagone, P; Wright, JF; Nathwani, AC; Nienhuis, AW; Davidoff, AM; Gray, JT; (2012) Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods. HUMAN GENE THERAPY METHODS , 23 (1) pp. 1-7. 10.1089/hgtb.2011.104.

Fields, PA; Linch, DC; (2012) Treatment of the elderly patient with diffuse large B cell lymphoma. Br J Haematol , 157 (2) pp. 159-170. 10.1111/j.1365-2141.2011.09011.x.

Flaherty, K; Metric Study Group, ; (2012) Improved survival with MEK inhibition in BRAF-mutated melanoma. New England Journal of Medicine 10.1056/NEJMoa1203421.

Flanagan, AM; Presneau, N; (2012) MicroRNA and NF1 tumorigenesis. In: Neurofibromatosis Type 1: Molecular and Cellular Biology. (pp. 611-623).

Foley, J; Butenas, S; Mann, K; Brummel-Ziedins, K; (2012) Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation. Analytical Biochemistry , 422 (1) pp. 46-51. 10.1016/j.ab.2011.12.036.

Foley, J; Ferris, L; Brummel-Ziedins, K; (2012) Characteristics of Fibrin Formation and Clot Stability in Individuals with Congenital Type IIb Protein C Deficiency. Thrombosis Research , 129 (4) e142-e146. 10.1016/j.thromres.2011.12.020.

Foley, JH; Petersen, K-U; Rea, CJ; Harpell, L; Powell, S; Lillicrap, D; Nesheim, ME; (2012) Solulin increases clot stability in whole blood from humans and dogs with hemophilia. Blood , 119 (15) pp. 3622-3628. 10.1182/blood-2011-11-392308.

Forster, M; Mendes, R; Fedele, S; (2012) Synthetic Lethality and PARP-Inhibitors in Oral and Head & Neck Cancer. CURRENT PHARMACEUTICAL DESIGN , 18 (34) pp. 5431-5441. 10.2174/138161212803307608.

Funes, JM; Kaufman, R; Flanagan, JM; Henderson, S; Robson, M; Pedley, B; Moncada, S; (2012) Putative role of Nrf2 as a tumor suppressor through inhibition of angiogenesis. CANCER RESEARCH , 72 10.1158/1538-7445.AM2012-2067.

G

Galarza, FFG; Marsh, SGE; Fernandez-Vina, M; Mack, S; Hollenbach, J; Middleton, D; (2012) THE RARE HLA ALLELES PROJECT: EXTENDING THE NUMBER OF RESOURCES AND BIOINFORMATICS ANALYSIS. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 549). WILEY-BLACKWELL

Gardiner, C; (2012) Guidelines for Evaluation of Coagulation Analyzer and Coagulation Testing, in Laboratory Hematology Practice. In: UNSPECIFIED Wiley-Blackwell

Gardiner, C; (2012) Guidelines for Evaluation of Coagulation Analyzers and Coagulation Testing. In: Laboratory Hematology Practice. (pp. 543-551).

Gardiner, C; Dragovic, R; Tannetta, D; Harrison, P; Redman, C; Sargent, I; (2012) CHARACTERISATION OF EXTRACELLULAR VESICLES BY MULTI-PARAMETER NANOPARTICLE TRACKING ANALYSIS. Presented at: UNSPECIFIED.

Gerrard, G; Mudge, K; Foskett, P; Stevens, D; Alikian, M; White, HE; Cross, NCP; ... Foroni, L; + view all (2012) Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: Innovation, automation, and harmonization. AMERICAN JOURNAL OF HEMATOLOGY , 87 (7) pp. 717-720. 10.1002/ajh.23212.

Gerrard, G; Valganon, M; Foong, HE; Kasperaviciute, D; Mueller, M; Game, L; Iskander, D; ... Karadimitris, A; + view all (2012) Target Enrichment and High-Throughput Sequencing of 80 Ribosomal Protein Genes to Identify Mutations Associated with Diamond-Blackfan Anaemia. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Ghorashian, S; Holler, A; Carpenter, B; Ahmadi, M; Nicholson, E; Zech, M; Xue, SA; ... Chakraverty, R; + view all (2012) CD4 cells expressing an MHC class I restricted TCR can rescue CD8 cells tolerized to tumour-associated antigen. In: (Proceedings) European Congress of Immunology. (pp. p. 707). WILEY-BLACKWELL

Ghorashian, S; Holler, A; Flutter, B; Xue, S-A; Fallah-Arani, F; Sivakumaran, J; Bennett, C; ... Chakraverty, R; + view all (2012) CD4 help can overcome tolerance developing in adoptively-transferred T cells transduced with a self-specific TCR. In: (Proceedings) Annual Conference of the British-Society-for-Gene-Therapy (BSGT). (pp. A6-A6). MARY ANN LIEBERT INC

Gissel, M; Orfeo, T; Foley, JH; Butenas, S; (2012) Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. Thrombosis Research , 130 (6) pp. 948-955. 10.1016/j.thromres.2012.08.299.

Giugliani, R; Boudes, P; Germain, DP; Fernhoff, P; Nichols, K; Hughes, D; Mehta, A; ... Sitaraman, S; + view all (2012) Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries. Presented at: 8th Annual World Symposium of the Lysosomal Disease Network, San Diego, CA.

Glynne-Jones, R; James, R; Meadows, H; Begum, R; Cunningham, D; Northover, J; Ledermann, JA; ... Sebag-Montefiore, D; + view all (2012) Optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance CisP/5FU in squamous cell carcinoma of the anus: Results of ACT II. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Glynne-Jones, R; James, R; Meadows, H; Begum, R; Cunningham, D; Northover, J; Ledermann, JA; ... Sebag-Montefiore, D; + view all (2012) Optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance CisP/5FU in squamous cell carcinoma of the anus: Results of ACT II. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Goncalves, M; Walker-Samuel, S; Johnson, SP; Pedley, RB; Lythgoe, MF; (2012) Investigating Tumour Vascular Connectivity With MRI and Independent Component Analysis. In: (Proceedings) 22nd Biennial Congress of the European-Association-for-Cancer-Research. (pp. S205-S205). ELSEVIER SCI LTD

Goodwin, R; Giaccone, G; Calvert, H; Lobbezoo, M; Eisenhauer, EA; (2012) Targeted agents: How to select the winners in preclinical and early clinical studies? EUROPEAN JOURNAL OF CANCER , 48 (2) pp. 170-178. 10.1016/j.ejca.2011.09.024.

Green, CL; (2012) Studies on CEBPA mutations in acute myeloid leukaemia. Doctoral thesis , UCL (University College London). Green open access
file

Green, L; Safa, O; Machin, SJ; Mackie, IJ; Ryland, K; Cohen, H; Lawrie, AS; (2012) Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway. THROMBOSIS RESEARCH , 130 (5) pp. 780-784. 10.1016/j.thromres.2011.12.034.

Griffin, J; Carpenter, B; Nicholson, E; Ghorasian, S; Holler, A; Velica, P; Xue, S; (2012) Gaining an advantage: mycophenolate-resistance for adoptively transferred cells. In: (Proceedings) European Congress of Immunology. (pp. p. 742). WILEY-BLACKWELL

Griffin, JE; Carpenter, B; Nicholson, E; Xue, S-A; Pule, M; Stauss, H; Chakraverty, R; (2012) In Vivo Selection of Mycophenolate Mofetil-Resistant T Cells for Adoptive Immunotherapy. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Guppy, NJ; El-Bahrawy, ME; Kocher, HM; Fritsch, K; Qureshi, YA; Poulsom, R; Jeffery, RE; ... Alison, MR; + view all (2012) Trefoil Factor Family Peptides in Normal and Diseased Human Pancreas. PANCREAS , 41 (6) pp. 888-896. 10.1097/MPA.0b013e31823c9ec5.

Gurung, PMS; Williamson, M; West, C; Counsell, N; Ahmed, A; Benthani, F; Feber, A; ... Kelly, JD; + view all (2012) The tumour suppressor gene, AIMP3 sensitises bladder cancer to chemo/radiotherapy in vitro and is a prognostic marker for overall survival in patients treated with radiotherapy for muscle invasive disease. EUROPEAN UROLOGY SUPPLEMENTS , 11 (1) E669-U430.

Gurung, PMS; Williamson, M; West, C; Counsell, N; Feber, A; Dewinter, P; Powles, T; ... Kelly, JD; + view all (2012) The tumour suppressor gene, AIMP3 sensitises bladder cancer to chemo/radiotherapy in vitro and is a prognostic marker for overall survival in patients treated with radiotherapy for muscle invasive disease. In: (Proceedings) Annual Meeting of the Society-of-Academic-and-Research-Surgery. (pp. p. 4). WILEY-BLACKWELL

H

Hackshaw, A; (2012) The Benefits and Harms of Mammographic Screening for Breast Cancer: Building the Evidence Base Using Service Screening Programmes. Journal of Medical Screening , 19 (1_suppl) pp. 1-2. 10.1258/jms.2012.012074.

Hackshaw, A; (2012) Benefits and harms of mammography screening. BMJ , 344 (jan06 1) d8279-d8279. 10.1136/bmj.d8279.

Hammond, JA; Marsh, SGE; Robinson, J; Davies, CJ; Stear, MJ; Ellis, SA; (2012) Cattle MHC nomenclature: is it possible to assign sequences to discrete class I genes? IMMUNOGENETICS , 64 (6) pp. 475-480. 10.1007/s00251-012-0611-7.

Hardwick, N; Ledermann, JA; Aitkens, E; Chain, B; (2012) Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease. CANCER IMMUNOLOGY IMMUNOTHERAPY , 61 (11) pp. 1929-1939. 10.1007/s00262-012-1252-2.

Hardwick, N; Ledermann, JA; Aitkens, E; Chain, B; (2012) Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease. Cancer Immunology, Immunotherapy , 61 (11) pp. 1929-1939. 10.1007/s00262-012-1252-2.

Harrison, P; Gardiner, C; (2012) Invisible vesicles swarm within the iceberg. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 10 (5) pp. 916-918. 10.1111/j.1538-7836.2012.04711.x.

Hart, AJ; Quinn, PD; Lali, F; Sampson, B; Skinner, JA; Powell, JJ; Nolan, J; ... Mosselmans, JF; + view all (2012) Cobalt from metal-on-metal hip replacements may be the clinically relevant active agent responsible for periprosthetic tissue reactions. Acta Biomater , 8 (10) 3865 - 3873. 10.1016/j.actbio.2012.05.003.

Helgason, GV; Allan, E; Galavotti, S; Audia, A; Hamilton, A; Mukhopadhyay, A; Karvela, M; ... Holyoake, TL; + view all (2012) Ponatinib and inhibition of the PI3K/Akt/mTOR pathway induces cell death and protective autophagy in TKI-resistant CML stem/progenitor cells. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 1). WILEY-BLACKWELL

Hollenbach, JA; Madbouly, A; Gragert, L; Vierra-Green, C; Flesch, S; Spellman, S; Begovich, A; ... Maiers, M; + view all (2012) A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics pp. 1-11.

Holme, H; Mun, KS; (2012) Postnatally diagnosed neonatal lupus. Arch Dis Child Fetal Neonatal Ed , 97 (2) F132-. 10.1136/archdischild-2011-301016.

Holme, H; Westbury, C; Morgenstern, D; Erturan, G; Tirabosco, R; Pollock, R; Briggs, T; ... Michelagnoii, M; + view all (2012) Management of paediatric desmoid fibromatosis. Archives of Disease in Childhood , 97 (Suppl 1) A86.2-A86. 10.1136/archdischild-2012-301885.207.

Howie, AJ; (2012) Diagnosis of amyloid using Congo red. In: Picken, MM and Dogan, A and Herrera, G, (eds.) Amyloid and related disorders: surgical pathology and clinical correlations. (pp. 167-174). Springer: New York, USA.

Howie, AJ; Owen-Casey, MP; (2012) 'Apple-green birefringence' of amyloid stained by Congo red. KIDNEY INTERNATIONAL , 82 (1) p. 114. 10.1038/ki.2012.89.

Hughes, D; Deegan, P; Romero, B; Hollak, C; Giugliani, R; (2012) Pregnancy Events in Females with Fabry Disease in the Fabry Outcome Survey. Presented at: 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks, San Diego, CA.

Huq, FY; Kulkarni, A; Agbim, EC; Riddell, A; Tuddenham, E; Kadir, RA; (2012) Changes in the levels of factor VIII and von Willebrand factor in the puerperium. HAEMOPHILIA , 18 (2) pp. 241-245. 10.1111/j.1365-2516.2011.02625.x.

Hurley, CK; Wang, T; Spellman, SR; Umejiego, J; Aljurf, M; Askar, M; Battiwalla, M; ... Woolfrey, A; + view all (2012) IMPACT OF HLA UNIDIRECTIONAL MISMATCHES ON THE OUTCOME OF UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 407). WILEY-BLACKWELL

Häusser, M; Spruston, N; Stuart, G; (2012) Conclusion. In: UNSPECIFIED

J

Jayakody, SA; (2012) Investigating genetic factors underlying hypopituitarism and septo-optic dysplasia in humans. Doctoral thesis , UCL (University College London).

Jenkinson, S; Koo, K; Goulden, N; Vora, A; Mitchell, C; Wade, R; Richards, SM; ... Gale, RE; + view all (2012) Presence of mutations in the NOTCH1 signalling pathway has a beneficial impact on outcome in paediatric T-ALL patients treated on the MRC UKALL2003 trial. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 19-20). WILEY-BLACKWELL

Jeyapalan, JN; Patel, SN; Forshew, T; Lawson, ARJ; Tatevossian, RG; Corbett-Jones, T; Mumin, MA; ... Sheer, D; + view all (2012) MICRORNA SIGNATURES IN A BROAD COHORT OF PAEDIATRIC BRAIN TUMOURS. In: (pp. p. 1084). WILEY PERIODICALS, INC

Jorgensen, M; Cheng, D; Goulden, N; Vora, A; Shankar, A; Hough, R; Grandage, V; (2012) LOW EFFICACY OF ROUTINE CSF SURVEILLANCE IN DETECTING ASYMPTOMATIC CNS RELAPSE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. In: (pp. p. 973). WILEY PERIODICALS, INC

K

Kammertoens, T; Qin, Z; Briesemeister, D; Bendelac, A; Blankenstein, T; (2012) B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin). Int J Cancer , 131 (7) pp. 1499-1508. 10.1002/ijc.27411.

Kanhere, A; Jenner, RG; (2012) Noncoding RNA localisation mechanisms in chromatin regulation. Silence , 3 (1) 2-. 10.1186/1758-907X-3-2. Gold open access

Kapoor, RR; James, CT; Hussain, K; (2012) HNF4A and hyperinsulinemic hypoglycemia. Frontiers in Diabetes , 21 pp. 182-190. 10.1159/000334532.

Kapoor, RR; James, CT; Hussain, K; (2012) HNF4A and hyperinsulinemic hypoglycemia. pp. 182-190. 10.1159/000334532.

Karwacz, K; Arce, F; Bricogne, C; Kochan, G; Escors, D; (2012) PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy. ONCOIMMUNOLOGY , 1 (1) pp. 86-88. 10.4161/onci.1.1.17824.

Kashima, T; Halai, D; Ye, H; Hing, SN; Delaney, D; Pollock, R; O'Donnell, P; ... Flanagan, AM; + view all (2012) Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor. MODERN PATHOLOGY , 25 (10) pp. 1384-1396. 10.1038/modpathol.2012.90.

Keeling, L; Suvarna, SK; Hughes, DA; (2012) Female Anderson-Fabry disease mimicking hypertrophic cardiomyopathy. JOURNAL OF CLINICAL PATHOLOGY , 65 (4) pp. 377-378. 10.1136/jclinpath-2011-200166.

Khan, I; Sarker, SJ; Hackshaw, AK; (2012) Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power. British Journal of Cancer , 107 1801 -1809. 10.1038/bjc.2012.444. Green open access
file

Khan, MS; Thirlwell, C; Toumpanakis, C; Caplin, M; Meyer, T; (2012) An Acute Shower of Circulating Tumour Cells Following Transarterial Embolisation (TAE). In: (Proceedings) Digestive Disease Week (DDW). (pp. S763-S763). W B SAUNDERS CO-ELSEVIER INC

Khan, MS; Tsigani, T; Garcia-Hernandez, J; Hartley, JA; Caplin, ME; Meyer, T; (2012) Circulating tumor cells as prognostic and predictive markers in neuroendocrine tumors. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Knight, A; Arnouk, H; Gillespie, G; Britt, W; Su, Y; Lowdell, MW; Lamb, LS; (2012) CYTOMEGALOVIRUS-INDEPENDENT LYSIS OF GLIOMA-DERIVED CELL LINES AND PRIMARY TUMOR EXPLANTS BY IN VITRO EXPANDED/ACTIVATED V Delta 1+Gamma Delta T CELLS. In: (Proceedings) 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO). (pp. p. 38). OXFORD UNIV PRESS INC

L

Labit, H; Fujimitsu, K; Bayin, NS; Takaki, T; Gannon, J; Yamano, H; (2012) Dephosphorylation of Cdc20 is required for its C-box-dependent activation of the APC/C. EMBO JOURNAL , 31 (15) pp. 3351-3362. 10.1038/emboj.2012.168.

Lambertsen, KL; Anthony, DC; Couch, Y; Martin, NA; Ormhoj, M; Schmidt, M-LB; Deierborg, T; ... Clausen, BH; + view all (2012) Anti-TNF therapy improves behavioural outcomes after focal cerebral ischemia in mice. In: (Proceedings) 11th International Congress of Neuroimmunology (ISNI). (pp. p. 101). ELSEVIER SCIENCE BV

Last, V; Williams, A; Werling, D; (2012) Inhibition of cytosolic Phospholipase A(2) prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin. BMC NEUROSCIENCE , 13 (ARTN 106) 10.1186/1471-2202-13-106. Gold open access

Laufer, J; Johnson, P; Zhang, E; Treeby, B; Coxa, B; Pedley, B; Beard, P; (2012) In vivo preclinical photoacoustic imaging using alloptical detection and time-reversal image reconstruction. Biomedical Optics, BIOMED 2012

Lechner, M; (2012) Genomic and Epigenomic Analysis of HPV positive and HPV negative Head and Neck Squamous Cell Cancer. Doctoral thesis , UCL (University College London). Green open access
file

Ledermann, JA; (2012) Olaparib in Platinum-Sensitive Ovarian Cancer REPLY. NEW ENGLAND JOURNAL OF MEDICINE , 367 (2) pp. 179-180.

Ledermann, JA; (2012) PROGRESS IN OVARIAN CANCER TREATMENT THROUGH GCIG COLLABORATIVE TRIALS. In: (Proceedings) 10th Annual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO). (pp. p. 9). OXFORD UNIV PRESS

Ledermann, JA; (2012) The author replies. New England Journal of Medicine , 367 (2) pp. 179-180. 10.1056/NEJMc1205423.

Lee, M; Satam, V; Babu, B; Gregory, M; Bowerman, M; Savagian, M; Lee, M; ... Hartley, JA; + view all (2012) Complete analysis on the two base pair sequence recognition by Hx (p-anisylbenzimidazole)center dot pyrrole and Hx center dot imidazole pairings. In: (Proceedings) 244th National Fall Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Lee, M; Satam, V; Babu, B; Porte, A; Savagian, M; Lee, MD; Liu, Y; ... Hartley, JA; + view all (2012) Synthesis and DNA binding properties of 1-(3-aminopropyl)imidazole-containing triamide f-Im*PyIm: a novel diamino polyamide designed to target 5 '-ACGCGT-3 '. In: (Proceedings) 244th National Fall Meeting of the American-Chemical-Society (ACS). AMER CHEMICAL SOC

Lemech, C; Infante, J; Arkenau, H-T; (2012) The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY , 4 (2) pp. 61-73. 10.1177/1758834011432949. Gold open access

Liao, Y-L; Hu, L-Y; Tsai, K-W; Wu, C-W; Chan, W-C; Li, S-C; Lai, C-H; ... Lin, W-C; + view all (2012) Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells. Carcinogenesis , 33 (4) pp. 760-769. 10.1093/carcin/bgs023.

Lowdell, MW; (2012) Natural Killer T cells - balancing the regulation of tumor immunity. Br J Cancer , 107 (10) pp. 1795-1796. 10.1038/bjc.2012.453.

Lowdell, MW; Birchall, M; Thrasher, AJ; (2012) Use of compassionate-case ATMP in preclinical data for clinical trial applications. LANCET , 379 (9834) p. 2341. 10.1016/S0140-6736(12)61018-6.

Lowdell, MW; Samuel, E; (2012) Processing of Cells for Transplantation. In: Tissue and Cell Processing: An Essential Guide. (pp. 271-292).

Lown, RN; Shaw, BE; (2012) 'First do no harm': where do we stand on unrelated hematopoietic cell donor safety? Expert Rev Hematol , 5 (3) pp. 249-252. 10.1586/ehm.12.22.

Lu, S-J; Rodriguez-Justo, M; Read, S; Bomanji, JB; (2012) Metabolic-Morphologic Discordant Solitary Skeletal Muscle Metastasis on [F-18]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan in Synchronous Lung and Esophageal Cancer: A Lesson. JOURNAL OF CLINICAL ONCOLOGY , 30 (8) E97-E101. 10.1200/JCO.2011.38.9205.

Lucas, G; Win, N; Calvert, A; Green, A; Griffin, E; Bendukidze, N; Hopkins, M; ... Massey, E; + view all (2012) Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines. VOX SANGUINIS , 103 (1) pp. 10-17. 10.1111/j.1423-0410.2011.01570.x.

Lytras, D; Kalaitzakis, E; Webster, GJM; Imber, CJ; Amin, Z; Rodriguez-Justo, M; Pereira, SP; ... Malago', M; + view all (2012) Cholangiocarcinoma or IgG4-Associated Cholangitis How Feasible It Is to Avoid Unnecessary Surgical Interventions? ANNALS OF SURGERY , 256 (6) pp. 1059-1067. 10.1097/SLA.0b013e3182533a0a.

M

Ma, G; Hall, AR; Green, AC; Manousou, P; Tsochatzis, E; Gale, J; Burgess, G; ... Dhillon, AP; + view all (2012) Ishak stage and quantitative fibrosis measurement (collagen proportionate area) progression in post liver transplant (post-LT) patients with chronic hepatitis C infection. In: (Proceedings) 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). (pp. 777A-777A). WILEY-BLACKWELL

Maharaj, L; Popat, R; Gribben, JG; Joel, S; (2012) IL-6, IL-8 and VEGF Neutralisation Restores Drug Sensitivity to Conventional and Novel Treatment Combinations in a Multiple Myeloma Bone Marrow Micro-Environment Model. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Majumder, B; (2012) An investigation into the role of platelet- monocyte interaction and inflammation in coronary artery disease. Doctoral thesis , UCL (University College London). Green open access
file

Majumder, B; North, J; Mavroudis, C; Rakhit, R; Lowdell, MW; (2012) Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategy. Cytometry Part B - Clinical Cytometry , 82 B (6) pp. 353-359. 10.1002/cyto.b.21040.

Majumder, B; North, J; Mavroudis, C; Rakhit, R; Lowdell, MW; (2012) Toward new insights on the white blood cell differential by flow cytometry: A proof of concept study on the sepsis model. CYTOMETRY PART B-CLINICAL CYTOMETRY , 82B (6) pp. 353-359. 10.1002/cyto.b.21027.

Malam, Y; Tsui, J; El Sheikh, S; Tuddenham, EGD; Baker, DM; (2012) Haemophilic pseudotumour of the carotid artery. VASCULAR MEDICINE , 17 (3) pp. 193-194. 10.1177/1358863X11429998.

Manousou, P; Burroughs, AK; Tsochatzis, E; Isgro, G; Hall, AR; Green, AC; Calvaruso, V; ... Dhillon, AP; + view all (2012) Assessment of progression of fibrosis in recurrent HCV after liver transplantation by digital image analysis of collagen. In: (Proceedings) 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). (pp. 528A-528A). WILEY-BLACKWELL

Manousou, P; Tsochatzis, E; Hall, AR; Thalassinos, E; Papastergiou, V; Rodriguez-Peralvarez, M; Germani, G; ... Burroughs, AK; + view all (2012) Antiviral treatment in HCV post LT modulates fibrosis progression evaluated by CPA regardless of achieving SVR. In: (Proceedings) 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD). (pp. 532A-533A). WILEY-BLACKWELL

Marquardt, J; Begent, RHJ; Chester, K; Huston, JS; Bradbury, A; Scott, JK; Thorpe, PE; ... Weiner, LM; + view all (2012) IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA. MAbs , 4 (6) pp. 648-652. 10.4161/mabs.22221.

Marsh, SG; (2012) Nomenclature for factors of the HLA system, update February 2012. Human Immunology , 73 (7) pp. 767-771. 10.1016/j.humimm.2012.04.001.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update April 2012. TISSUE ANTIGENS , 80 (3) pp. 280-285. 10.1111/j.1399-0039.2012.01945.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update April 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 532-537. 10.1111/j.1744-313X.2012.01148.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update August 2012. TISSUE ANTIGENS , 80 (6) pp. 560-563. 10.1111/tan.12031.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update December 2011. HUMAN IMMUNOLOGY , 73 (4) pp. 435-438. 10.1016/j.humimm.2012.01.003.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update December 2011*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 275-278. 10.1111/j.1744-313X.2012.01100.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update February 2012. TISSUE ANTIGENS , 80 (1) pp. 72-77. 10.1111/j.1399-0039.2012.01882.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update February 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (4) pp. 365-369. 10.1111/j.1744-313X.2012.01127.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update July 2012. TISSUE ANTIGENS , 80 (6) pp. 555-559. 10.1111/tan.12030.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update June 2012. TISSUE ANTIGENS , 80 (3) pp. 289-293. 10.1111/j.1399-0039.2012.01947.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update June 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 541-545. 10.1111/j.1744-313X.2012.01150.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update March 2012. TISSUE ANTIGENS , 80 (2) pp. 202-204. 10.1111/j.1399-0039.2012.01888.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update March 2012. HUMAN IMMUNOLOGY , 73 (8) pp. 867-869. 10.1016/j.humimm.2012.04.002.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update March 2012*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (4) pp. 370-372. 10.1111/j.1744-313X.2012.01128.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update May 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 538-540. 10.1111/j.1744-313X.2012.01149.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update November 2011. TISSUE ANTIGENS , 79 (3) pp. 222-229. 10.1111/j.1399-0039.2012.01840.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update November 2011. HUMAN IMMUNOLOGY , 73 (3) pp. 320-325. 10.1016/j.humimm.2012.01.002.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update November 2011*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 268-274. 10.1111/j.1744-313X.2012.01099.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update October 2011. HUMAN IMMUNOLOGY , 73 (4) pp. 432-434. 10.1016/j.humimm.2012.01.001.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update September 2012. TISSUE ANTIGENS , 80 (6) pp. 564-569. 10.1111/tan.12034.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2012) Nomenclature for factors of the HLA system, update January 2012. Tissue Antigens , 79 (5) pp. 393-397. 10.1111/j.1399-0039.2012.01856.x.

Marzolini, M; Dorman, J; O'Leary, C; Thomson, K; D'Sa, S; (2012) Autologous stem cell transplantation can improve the quality of response in lymphoplasmacytic lymphoma/waldenstrom macroglobulinaemia with a median time to best response of 5 months. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 86). WILEY-BLACKWELL

Marzolini, M; Wong, WL; Ardeshna, K; Padhani, A; D'Sa, S; (2012) Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma. Br J Haematol , 156 (5) 557-. 10.1111/j.1365-2141.2011.08959.x.

Marzolini, MAV; Poggiali, E; Badat, M; Cassinerio, E; Cappellini, MD; Porter, JB; (2012) Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders. In: (pp. p. 1155).

Mavroudis, CA; Eleftheriou, D; Majumder, B; Sapsford, R; North, J; Lowdell, M; Brogan, P; (2012) DEMONSTRATION OF INTRACORONARY MICROPARTICLE EXPRESSION AND THEIR ASSOCIATION WITH ACTIVATED PLATELET MONOCYTE AGGREGATE IN HUMAN ST ELEVATION MYOCARDIAL INFARCTION. In: (Proceedings) Annual Conference of the British-Cardiovascular-Society (BCS). (pp. A71-A72). B M J PUBLISHING GROUP

Mayor, NP; Shaw, BE; Madrigal, JA; Marsh, SGE; (2012) NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome. Bone Marrow Res , 2012 180391-. 10.1155/2012/180391.

McNeill, A; Hughes, D; Mehta, A; Schapira, A; (2012) Hyposmia and cognitive impairment in gaucher disease patients and carriers. Presented at: British Human Genetics Conference, Univ Warwick, Coventry, ENGLAND.

Mehta, V; Abi-Nader, KN; Peebles, DM; Benjamin, E; Wigley, V; Torondel, B; Filippi, E; ... David, AL; + view all (2012) Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep. GENE THERAPY , 19 (9) pp. 925-935. 10.1038/gt.2011.158.

Mendoza-Naranjo, A; Contreras-Vallejos, E; Henriquez, DR; Otth, C; Bamburg, JR; Maccioni, RB; Gonzalez-Billault, C; (2012) Fibrillar amyloid-β1-42 modifies actin organization affecting the cofilin phosphorylation state: a role for Rac1/cdc42 effector proteins and the slingshot phosphatase. J Alzheimers Dis , 29 (1) pp. 63-77. 10.3233/JAD-2012-101575.

Mendoza-Naranjo, A; Wai, DH; Farrar, JE; Zhu, Q; Mistry, P; Lazic, N; Rojas Ayala, FR; ... Sorensen, PH; + view all (2012) EbB4 is a novel driver of metastasis and anoikis resistance in Ewing's sarcoma. In: (Proceedings) Cancer Research: April 15, 2012; Volume 72, Issue 8, Supplement 1. © 2012 American Association for Cancer Research

Meyer, T; Caplin, M; Reed, N; Qian, W; Lao-Sirieix, S; Armstrong, G; Valle, J; ... Corrie, P; + view all (2012) TREATMENT OF ADVANCED NEUROENDOCRINE TUMOURS: FINAL RESULTS OF THE UKINETS AND NCRI RANDOMISED PHASE 2 NET01 TRIAL. In: (Proceedings) 37th Congress of the European-Society-for-Medical-Oncology (ESMO). (pp. pp. 378-379). OXFORD UNIV PRESS

Meyer, T; Fox, R; Bird, D; Watkinson, A; Hacking, N; Stocken, D; Johnson, P; (2012) TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC). In: (Proceedings) ASCO Annual Meeting. (pp. 4150-).

Milius, B; Schneider, J; Heuer, M; Bashyal, P; George, M; Schneyman, D; Pollack, J; ... Maiers, M; + view all (2012) TOOLS FOR IMPLEMENTATION OF SILVER STANDARD PRINCIPLES FOR HLA TYPING. In: (Proceedings) 38th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. p. 8). ELSEVIER SCIENCE INC

Miller, CE; Pang, H; Brian, D; Pang, K; North, J; Shah, F; O'Shea, J; ... McNamara, C; + view all (2012) Transition to an integrated reporting system for bone marrow biopsies from patients with suspected haematological malignancy - experience in North Central London/West Essex. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 28-29). WILEY-BLACKWELL

Miller, J; Doss, M; McQuillen, R; Shaller, CC; Tolner, B; Yu, JQ; Chester, K; (2012) Impact of expression system on the function of the C6.5 diabody PET radiotracer. TUMOR BIOLOGY , 33 (3) pp. 617-627. 10.1007/s13277-012-0361-z.

Miller, J; Doss, M; McQuillen, R; Shaller, CC; Tolner, B; Yu, JQ; Chester, K; (2012) Impact of expression system on the function of the C6.5 diabody PET radiotracer. Tumor Biology pp. 1-11.

Milojkovic, D; Apperley, JF; Gerrard, G; Ibrahim, AR; Szydlo, R; Bua, M; Reid, A; ... Marin, D; + view all (2012) Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients. BLOOD , 119 (8) pp. 1838-1843. 10.1182/blood-2011-10-383000.

Miranda, E; Maya Pineda, H; Öberg, D; Cherubini, G; Garate, Z; Lemoine, NR; Halldén, G; (2012) Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region. PLoS ONE , 7 (10) , Article e46617. 10.1371/journal.pone.0046617. Green open access
file

Moore, S; Peggs, K; Thomson, K; Lowry, L; Ljubic, A; Goldstone, AH; Linch, DC; (2012) Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy. BRITISH JOURNAL OF HAEMATOLOGY , 156 (1) pp. 142-144. 10.1111/j.1365-2141.2011.08818.x.

Moorman, AV; Schwab, C; Ensor, HM; Russell, LJ; Morrison, H; Jones, L; Masic, D; ... Harrison, CJ; + view all (2012) IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic Leukemia. JOURNAL OF CLINICAL ONCOLOGY , 30 (25) pp. 3100-3108. 10.1200/JCO.2011.40.3907.

N

Nagano, K; Akpan, A; Warnasuriya, G; Corless, S; Totty, N; Yang, A; Stein, R; ... Naaby-Hansen, S; + view all (2012) Functional Proteomic Analysis of Long-term Growth Factor Stimulation and Receptor Tyrosine Kinase Coactivation in Swiss 3T3 Fibroblasts. Molecular & Cellular Proteomics , 11 (12) pp. 1690-1708. 10.1074/mcp.M112.019778. Green open access
file

Neelakantan, P; Gerrard, G; Foroni, L; Milojkovic, D; Apperley, J; Szydlo, R; Bua, M; ... Marin, D; + view all (2012) Can the Combination of the Measurement of BCR-ABL1 Transcript Levels At 3 and 6 Months Improve the Prognostic Value of the 3 Month Measurement? In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

O

Ooi, SKT; (2012) Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all–iPS cell mice from terminally differentiated B cells. Nature Genetics , 44 (4) pp. 398-405. 10.1038/ng.1110..

Ooi, SKT; (2012) Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all–iPS cell mice from terminally differentiated B cells. Nature Genetics , 44 (4) pp. 398-405. 10.1038/ng.1110..

Oseni, A; Crowley, C; Lowdell, M; Birchall, M; Butler, PE; Seifalian, AM; (2012) Advancing nasal reconstructive surgery: the application of tissue engineering technology. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE , 6 (10) pp. 757-768. 10.1002/term.487.

Owczarek, D; Undas, A; Foley, JH; Nesheim, ME; Jabłonski, K; Mach, T; (2012) Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases. Journal of Crohn's and Colitis , 6 (1) pp. 13-20. 10.1016/j.crohns.2011.06.005.

P

Palmer, D; Loembe, AB; Studeny, M; Hocke, J; Meyer, T; (2012) PHASE I STUDY OF NINTEDANIB (BIBF 1120) IN EUROPEAN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA. In: (Proceedings) 37th Congress of the European-Society-for-Medical-Oncology (ESMO). (pp. p. 245). OXFORD UNIV PRESS

Payne, NL; Sun, G; Herszfeld, D; Tat-Goh, PA; Verma, PJ; Parkington, HC; Coleman, HA; ... Bernard, CCA; + view all (2012) Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis. PLoS ONE , 7 (4) e35093-e35093. 10.1371/journal.pone.0035093.

Pekkonen, P; Cheng, F; Sugiyama, N; Henderson, S; Rantanen, V; Aavikko, M; Hautaniemi, S; ... Ojala, PM; + view all (2012) KSHV-initiated Notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. CANCER RESEARCH , 72 10.1158/1538-7445.AM2012-2976.

Perez-Medina, C; Patel, N; Robson, M; Badar, A; Lythgoe, MF; Arstad, E; (2012) Evaluation of a I-125-labelled benzazepinone derived voltage-gated sodium channel blocker for imaging with SPECT. ORGANIC & BIOMOLECULAR CHEMISTRY , 10 (47) pp. 9474-9480. 10.1039/c2ob26695d.

Pericleous, M; Lumgair, H; Reiner, J; Marelli, L; Caplin, M; Meyer, T; Toumpanakis, C; (2012) Bronchial neuroendocrine tumors: A retrospective review of management and outcomes in 116 patients. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Pericleous, M; Toumpanakis, C; Lumgair, H; Reiner, J; Marelli, L; Meyer, T; Caplin, M; (2012) Diagnostic Features and Management Outcomes in Bronchopulmonary Neuroendocrine Tumors: A Clinical Study of 116 Patients. In: (Proceedings) 9th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. (pp. p. 54). KARGER

Philip, B; Flutter, B; Chakraverty, R; Jathoul, A; Pule, M; (2012) A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy. In: (Proceedings) 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S35-S36). NATURE PUBLISHING GROUP

Pidala, J; Wang, T; Haagenson, MD; Spellman, S; Askar, M; Battiwalla, M; Baxter-Lowe, LA; ... Anasetti, C; + view all (2012) Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Ploquin, A; Olmos, D; Lacombe, D; A'Hern, R; Duhamel, A; Twelves, C; Marsoni, S; ... Penel, N; + view all (2012) Prediction of early death among patients enrolled in phase i trials: Development and validation of a new model based on platelet count and albumin. British Journal of Cancer , 107 (7) pp. 1025-1030. 10.1038/bjc.2012.371.

Powell, F; McWhinnie, AJ; Tavarozzi, F; Madrigal, JA; Marsh, SGE; Latham, K; (2012) THE DESIGN OF A PCR-SSP PANEL TO REDUCE HLA TYPING AMBIGUITIES ARISING FROM OUR CURRENT LOCAL SEQUENCE BASED TYPING PROTOCOL. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 447). WILEY-BLACKWELL

Prieto Hinojosa, AI; (2012) T cell subsets and the outcome of haematopoietic stem cell transplantation. Doctoral thesis , UCL (University College London). Green open access
file

R

Rabin, N; Percy, L; Khan, I; Quinn, J; D'Sa, S; Yong, KL; (2012) Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 158 (4) pp. 499-505. 10.1111/j.1365-2141.2012.09188.x.

Raja, FA; Counsell, N; Colombo, N; Parmar, MK; Pfisterer, J; Vergote, IB; Gonzalez Martin, A; ... Ledermann, JA; + view all (2012) PLATINUM COMBINATION CHEMOTHERAPY VERSUS PLATINUM MONOTHERAPY IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: A META-ANALYSIS OF RANDOMISED TRIALS USING INDIVIDUAL PATIENT DATA (IPD). In: (Proceedings) 37th Congress of the European-Society-for-Medical-Oncology (ESMO). (pp. p. 324). OXFORD UNIV PRESS

Raja, FA; Hook, JM; Ledermann, JA; (2012) Biomarkers in the development of anti-angiogenic therapies for ovarian cancer. CANCER TREATMENT REVIEWS , 38 (6) pp. 662-672. 10.1016/j.ctrv.2011.11.009.

Rajkumar, VS; Boxer, G; Robson, M; Muddle, J; Papastavrou, Y; Pedley, RB; (2012) A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma. TUMOR BIOLOGY , 33 (6) pp. 2019-2029. 10.1007/s13277-012-0461-9.

Rajkumar, VS; Boxer, G; Robson, M; Muddle, J; Papastavrou, Y; Pedley, RB; (2012) A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , 33 (6) pp. 2019-2029. 10.1007/s13277-012-0461-9.

Rallapalli, P; Gomez, K; Tuddenham, E; Perkins, S; (2012) Phenotypic classification of the mutations in coagulation factor IXx segregate to different locations in its protein structure. HAEMOPHILIA , 18 p. 187.

Ramasubramanyan, S; Kanhere, A; Osborn, K; Flower, K; Jenner, RG; Sinclair, AJ; (2012) Genome-Wide Analyses of Zta Binding to the Epstein-Barr Virus Genome Reveals Interactions in both Early and Late Lytic Cycles and an Epigenetic Switch Leading to an Altered Binding Profile. JOURNAL OF VIROLOGY , 86 (23) pp. 12494-12502. 10.1128/JVI.01705-12.

Rea, CJ; Foley, JH; Sørensen, B; (2012) Factor XIII in the Treatment of Hemophilia A. New England Journal of Medicine , 366 (3) pp. 281-283. 10.1056/NEJMc1113270.

Reading, JL; Meyers, AF; Vyakarnam, A; (2012) Whey acidic proteins (WAPs). Current Opinion in HIV and AIDS , 7 (2) pp. 172-179. 10.1097/COH.0b013e32835005d9.

Redman, C; Tannetta, D; Southcombe, J; Dragovic, B; Gardiner, C; Collett, G; Sargent, I; (2012) THE DANGEROUS PLACENTA AND PRE-ECLAMPSIA, A REVIEW. In: (Proceedings) Meeting of the International-Federation-of-Placenta-Associations (IFPA). (pp. A12-A12). W B SAUNDERS CO LTD

Reza, M; Johnson, D; Cox, D; Laval, S; Chaouch, A; Barresi, R; Morgan, J; ... Lochmueller, H; + view all (2012) MRC NMD Centre Biobank: An overview. In: (Proceedings) United Kingdom Neuromuscular Translational Research Conference. (pp. S34-S34). PERGAMON-ELSEVIER SCIENCE LTD

Riccombeni, A; Butler, G; (2012) Role of Genomics and RNA-seq in Studies of Fungal Virulence. Current Fungal Infection Reports pp. 1-8.

Richardson, E; Stockwell, SR; Li, H; Aherne, W; Cuomo, ME; Mittnacht, S; (2012) Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response. PLOS ONE , 7 (2) , Article e31627. 10.1371/journal.pone.0031627. Green open access
file

Rizvi, H; Paterson, JC; Tedoldi, S; Ramsay, A; Calaminici, M; Natkunam, Y; Lonardi, S; ... Marafioti, T; + view all (2012) Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. Pathologica , 104 (2) pp. 56-64.

Robinson, J; Guethlein, LA; Halliwell, JA; Cereb, N; Marsh, SGE; Parham, P; (2012) IDENTIFICATION OF CORE HLA CLASS I ALLELES. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. pp. 550-551). WILEY-BLACKWELL

Robinson, J; Pollack, J; Walts, A; Schneider, J; Fritsch, R; Barber, A; Freeman, J; ... Marsh, SGE; + view all (2012) AN XML EXPORT OF THE IMGT/HLA DATABASE. In: (Proceedings) 38th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. p. 167). ELSEVIER SCIENCE INC

Robinson, J; Pollack, J; Walts, A; Schneider, J; Fritsch, R; Barber, A; Freeman, J; ... Marsh, SGE; + view all (2012) AN XML EXPORT OF THE IMGT/HLA DATABASE. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. pp. 547-548). WILEY-BLACKWELL

Rodriguez, ML; Germani, G; Thalassinos, E; Rolando, N; Luong, TV; Dhillon, AP; O'Beirne, J; ... Burroughs, AK; + view all (2012) MONITORING BLOOD EOSINOPHILS CAN PREDICT RESPONSE TO CORTICOSTEROIDS IN PATIENTS WITH ACUTE CELLULAR REJECTION AFTER LIVER TRANSPLANTATION. In: (Proceedings) 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S93-S93). ELSEVIER SCIENCE BV

Rollins-Raval, MA; Fuhrer, K; Marafioti, T; Roth, CG; (2012) ALDH, CA I, and CD2AP Novel, Diagnostically Useful Immunohistochemical Markers to Identify Erythroid Precursors in Bone Marrow Biopsy Specimens. AMERICAN JOURNAL OF CLINICAL PATHOLOGY , 137 (1) pp. 30-38. 10.1309/AJCP0QFQ0FTSZCPW.

S

Sabry, M; Lowdell, MW; (2012) Natural Killer Cell Responses to Tumor Priming. In: (Proceedings) 22nd Biennial Congress of the European-Association-for-Cancer-Research. (pp. S86-S86). ELSEVIER SCI LTD

Salomoni, P; Dvorkina, M; Michod, D; (2012) Role of the promyelocytic leukaemia protein in cell death regulation. CELL DEATH & DISEASE , 3 (ARTN e24) 10.1038/cddis.2011.122. Gold open access

Satam, V; Babu, B; Chavda, S; Savagian, M; Sjoholm, R; Tzou, S; Ramos, J; ... Lee, M; + view all (2012) Novel diamino imidazole and pyrrole-containing polyamides: Synthesis and DNA binding studies of mono- and diamino-phenyl-ImPy*Im polyamides designed to target 5 '-ACGCGT-3 ' (vol 20, pg 693, 2012). BIOORGANIC & MEDICINAL CHEMISTRY , 20 (15) p. 4881. 10.1016/j.bmc.2012.06.037.

Schellekens, J; Shaw, BE; Mayor, NP; Cooke, L; Madrigal, JA; Marsh, SGE; (2012) THE INFLUENCE OF PATIENT AND DONOR KIR HAPLOTYPES ON THE CLINICAL OUTCOME AFTER UNRELATED DONOR HSCT FOR PATIENTS SUFFERING FROM AML. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 467). WILEY-BLACKWELL

Schmukle, AC; Walczak, H; (2012) No one can whistle a symphony alone - how different ubiquitin linkages cooperate to orchestrate NF- B activity. Journal of Cell Science , 125 (3) pp. 549-559. 10.1242/jcs.091793.

Sebag-Montefiore, D; James, R; Meadows, H; Begum, R; Cunningham, D; Northover, J; Ledermann, JA; ... Glynne-Jones, R; + view all (2012) The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Sellar, RS; Peggs, KS; (2012) Management of multidrug-resistant viruses in the immunocompromised host. BRITISH JOURNAL OF HAEMATOLOGY , 156 (5) pp. 559-572. 10.1111/j.1365-2141.2011.08988.x.

Selmi, T; Martello, A; Vignudelli, T; Ferrari, E; Grande, A; Gemelli, C; Salomoni, P; ... Zanocco-Marani, T; + view all (2012) ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways. CELL CYCLE , 11 (10) pp. 1977-1987. 10.4161/cc.20309.

Sevko, A; Kremer, V; Falk, C; Umansky, L; Shurin, MR; Shurin, GV; Umansky, V; (2012) Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice. J Immunotoxicol , 9 (3) pp. 275-281. 10.3109/1547691X.2012.655343.

Sheeba, I; Kelleher, M; Lawler, K; Festy, F; Barber, P; Shamill, E; Gargi, P; ... Ng, T; + view all (2012) Abstract P2-10-29: Time dependent breast cancer metastasis prediction using novel biological imaging, clinico-pathological and genomic data combined with Bayesian modeling to reduce over-fitting and improve on inter-cohort reproducibility. Cancer Research , 72 (24 Suppl) P2-10-29-P2-10-29. 10.1158/0008-5472.SABCS12-P2-10-29.

Sidor, C.M.; (2012) Mask proteins are co-factors of Yorkie/YAP in the Hippo signaling pathway. Doctoral thesis , UCL (University College London). Green open access
file

Skelton, S; Moss, D; Sansom, C; Gomez, K; Shepherd, A; Hart, D; (2012) Novel MHC-PEPTIDE-T cell receptor interfaces are necessary for inhibitor formation in mild/moderate hemophilia A secondary to missense mutation genotypes. HAEMOPHILIA , 18 p. 86.

Skibola, CF; Conde, L; Smith, MT; Sille, FCM; (2012) Functional Characterization of HLA SNPs Associated with Risk of Follicular Lymphoma. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Slater, S; Witteveen, P; Plummer, R; Kristeleit, R; Evans, T; Reyderman, L; de las Heras, B; ... Schellens, J; + view all (2012) 599 Effect of Food On Relative Bioavailability of E7820 in Cancer Patients. European Journal of Cancer , 48 (S6) p. 184. 10.1016/S0959-8049(12)72396-1.

Smart, C; Brown, J; Kocjan, G; Proctor, I; (2012) Eosinophilic pleural effusion with Charcot-Leyden crystals in invasive aspergillosis. CYTOPATHOLOGY , 23 (5) pp. 340-342. 10.1111/j.1365-2303.2011.00902.x.

Sofueva, S; Hadjur, S; (2012) Cohesin-mediated chromatin interactions-into the third dimension of gene regulation. BRIEFINGS IN FUNCTIONAL GENOMICS , 11 (3) pp. 205-216. 10.1093/bfgp/elr048.

Spedale, G; Meddens, CA; Koster, MJE; Ko, CW; van Hooff, SR; Holstege, FCP; Timmers, HTM; (2012) Tight cooperation between Mot1p and NC2β in regulating genome-wide transcription, repression of transcription following heat shock induction and genetic interaction with SAGA. Nucleic Acids Res , 40 (3) pp. 996-1008. 10.1093/nar/gkr784.

Stadtfeld, M; Apostolou, E; Ferrari, F; Choi, J; Walsh, RM; Chen, T; Ooi, SS; ... Hochedlinger, K; + view all (2012) Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet , 44 398-S2. 10.1038/ng.1110.

Stankovic, T; Byrd, P; Francis, T; Marafioti, T; Rudzki, Z; Taylor, AMR; (2012) The Ataxia Telangiectasia Nude Mouse with No Risk of Thymoma: A Model to Investigate Tumour Development of B Cell and Myeloid Origin Associated with ATM Loss. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Straathof, K; Kokalaki, E; Philip, B; Himoudi, N; Pule, M; Anderson, J; (2012) T-CELLS GRAFTED WITH GD2-SPECIFIC ANTITUMOUR ACTIVITY: DEVELOPMENT OF IMMUNOTHERAPY FOR NEUROBLASTOMA. PEDIATRIC BLOOD & CANCER , 59 (6) p. 1006.

Sudres, M; Ciré, S; Vasseur, V; Brault, L; Da Rocha, S; Boisgérault, F; Le Bec, C; ... Galy, A; + view all (2012) MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV. Mol Ther , 20 (8) pp. 1571-1581. 10.1038/mt.2012.101.

Sørensen, B; Larsen, O; Rea, C; Tang, M; Foley, J; Fenger-Eriksen, C; (2012) Fibrinogen as a Hemostatic Agent. Seminars in Thrombosis and Hemostasis , 38 (03) pp. 268-273. 10.1055/s-0032-1309287.

T

Tamai, TK; Young, LC; Cox, CA; Whitmore, D; (2012) Light Acts on the Zebrafish Circadian Clock to Suppress Rhythmic Mitosis and Cell Proliferation. JOURNAL OF BIOLOGICAL RHYTHMS , 27 (3) pp. 226-236. 10.1177/0748730412440861.

Theodoulou, A; Berryman, J; Nathwani, A; Scully, M; (2012) Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. Transfusion and Apheresis Science , 46 (2) pp. 159-162. 10.1016/j.transci.2011.11.005.

Thirlwell, C; Feber, A; Lechner, M; Teschendorff, AE; Beck, S; (2012) Comments on: Interpretation of genome-wide infinium methylation data from ligated DNA in formalin-fixed paraffin-embedded paired tumor and normal tissue. BMC Res Notes , 5 631-. 10.1186/1756-0500-5-631. Gold open access

Thirlwell, C; Sasmaz, S; Dibra, H; Feber, A; Butcher, L; Meyer, T; Davidson, B; ... Beck, S; + view all (2012) The First Neuroendocrine Tumor Methylome Using Methylation-Specific Immunoprecipitation Followed by Second Generation Sequencing - MeDIP-seq. In: (Proceedings) 9th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. (pp. p. 14). KARGER

Tirabosco, R; Jacques, T; Berisha, F; Flanagan, AM; (2012) Assessment of integrase interactor 1 (INI-1) expression in primary tumours of bone. HISTOPATHOLOGY , 61 (6) pp. 1245-1247. 10.1111/j.1365-2559.2012.04346.x.

Tirabosco, R; Jacques, T; Berisha, F; Flanagan, AM; (2012) Assessment of integrase interactor 1 (INI-1) expression in primary tumours of bone. Histopathology , 61 (6) pp. 1245-1247. 10.1111/j.1365-2559.2012.04346.x.

Toumpanakis, C; Baneke, A; Pericleous, M; Meyer, T; Caplin, M; (2012) Goblet Cell Appendiceal Neuroendocrine Tumors: Diagnosis, Recurrence Rates, Treatment and Survival. A Series of 37 Patients. In: (Proceedings) 9th Annual European-Neuroendocrine-Tumor-Society (ENETS) Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. (pp. p. 64). KARGER

Toumpanakis, C; Baneke, A; Pericleous, M; Meyer, T; Caplin, ME; (2012) Diagnostic and therapeutic outcomes in goblet cell appendiceal neuroendocrine tumors. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Treins, C; Alliouachene, S; Hassouna, R; Xie, Y; Birnbaum, MJ; Pende, M; (2012) The combined deletion of S6K1 and Akt2 deteriorates glycemic control in a high-fat diet. Mol Cell Biol , 32 (19) pp. 4001-4011. 10.1128/MCB.00514-12.

Tsochatzis, EA; Meyer, T; Burroughs, AK; (2012) Hepatocellular carcinoma. N.Engl.J.Med. , 366 (1) pp. 92-93. 10.1056/NEJMc1112501#SA2.

Tuddenham, E; (2012) Development of genetics as a tool in bleeding disorder investigations during the 50-year development of the WFH. HAEMOPHILIA , 18 p. 101.

U

Umansky, V; Sevko, A; (2012) Melanoma-induced immunosuppression and its neutralization. Semin Cancer Biol , 22 (4) pp. 319-326. 10.1016/j.semcancer.2012.02.003.

Uttenthal, BJ; Carpenter, B; Ghorashian, S; Wright, GP; Flutter, B; Xue, SA; Chakraverty, R; (2012) Adoptive therapy with redirected MHC class I-restricted antigen-specific regulatory T cells is a potential novel cellular therapy for graft-versus-host disease. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 8). WILEY-BLACKWELL

V

Veeriah, S; (2012) Opposing roles of the oncogene Akt isoforms in tumour progression: is there a dark side to Akt pathway inhibition? J Chem Biol , 5 (3) pp. 115-117. 10.1007/s12154-012-0076-z.

Vincenzi, B; Santini, D; Schiavon, G; Frezza, AM; Dileo, P; Silletta, M; Bertoldo, F; ... Tonini, G; + view all (2012) Bone metastases in soft tissue sarcoma patients: A survey of natural, prognostic value, and treatment. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). AMER SOC CLINICAL ONCOLOGY

Vyas, S; Markar, S; Ezzat, T; Rodriguez-Justo, M; Webster, G; Imber, C; Malago, M; (2012) Hepato-biliary Cystadenoma with Intraductal Extension: Unusual Cause of Obstructive Jaundice. J Gastrointest Cancer , 43 Sup S32-S37. 10.1007/s12029-011-9289-6.

W

Walczak, H; Iwai, K; Dikic, I; (2012) Generation and physiological roles of linear ubiquitin chains. BMC Biology , 10 , Article 23. 10.1186/1741-7007-10-23. Green open access
file

Walker-Samuel, S; Ramasawmy, R; Wells, J; Siow, B; Johnson, SP; Pedley, RB; Lythgoe, MF; (2012) Non-invasive Measurement of Tumour Interstitial Fluid Pressure Using Magnetic Resonance Imaging. In: (Proceedings) 22nd Biennial Congress of the European-Association-for-Cancer-Research. (pp. S96-S96). ELSEVIER SCI LTD

Wallis-Jones, S; McWhinnie, AJ; Madrigal, JA; Latham, K; Marsh, SGE; (2012) TEN NOVEL HLA-A AND HLA-DRB1 ALLELES IDENTIFIED THROUGH GROUP SPECIFIC AMPLIFICATION AT ANTHONY NOLAN. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 438). WILEY-BLACKWELL

Weatherstone, K; Meyer, T; (2012) Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Targeted Oncology , 7 (3) pp. 161-168. 10.1007/s11523-012-0224-y.

Westrop, SJ; Lagos, D; Boshoff, C; Bower, M; Imami, N; (2012) African ancestry and innate immunity contribute to the incidence of multicentric Castleman's disease in HIV-1/Kaposi's sarcoma herpesvirus-coinfected individuals. FUTURE VIROLOGY , 7 (7) pp. 729-734. 10.2217/FVL.12.54.

Whelan, J; Hook, J; Bielack, SS; Marina, N; Smeland, S; Jovic, G; Krailo, MD; ... Bernstein, ML; + view all (2012) EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma. Presented at: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL.

Wilson, GA; Dhami, P; Feber, A; Cortazar, D; Suzuki, Y; Schulz, R; Schaer, P; (2012) Resources for methylome analysis suitable for gene knockout studies of potential epigenome modifiers. GIGASCIENCE , 1 (ARTN 3) 10.1186/2047-217X-1-3. Gold open access

Winckworth, LC; Holme, H; (2012) Question 3: Inhaled mannitol improves lung function in patients with cystic fibrosis. Arch Dis Child , 97 (11) pp. 1003-1006. 10.1136/archdischild-2012-302513.

Wong, HH; Parkinson, C; Ledermann, JA; Brenton, JD; Merger, M; Shaw, A; Patterson, A; ... Earl, HM; + view all (2012) Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation. Gynecol Oncol Case Rep , 3 pp. 7-10. 10.1016/j.gynor.2012.10.003.

Y

Yang, KL; Chu, CC; Marsh, SGE; Lin, PY; (2012) HLA-A*11:53 is shown to be identical to the corrected A*11:02:01 allele sequence. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 524-526. 10.1111/j.1744-313X.2012.01121.x.

Ye, H; Berisha, F; Alorjani, M; Eskandarpour, M; Diss, T; Tirabosco, R; Flanagan, AM; (2012) Detection of USP6 Gene Rearrangement in Nodular Fasciitis. An Important Diagnostic Tool. In: (Proceedings) Annual Meeting of the Association-for-Molecular-Pathology. (pp. p. 705). ELSEVIER SCIENCE INC

Z

Zech, M; Velica, P; Holler, A; Chakraverty, R; Stauss, H; (2012) Manipulating mTOR to enhance T cell mediated tumour immunity in vivo. In: (Proceedings) Annual Conference of the British-Society-for-Gene-Therapy (BSGT). (pp. A16-A16). MARY ANN LIEBERT INC

Zhang, T; Penicud, K; Bruhn, C; Loizou, JI; Kanu, N; Wang, Z-Q; Behrens, A; (2012) Competition between NBS1 and ATMIN controls ATM signaling pathway choice. Cell Rep , 2 (6) pp. 1498-1504. 10.1016/j.celrep.2012.11.002.

This list was generated on Sun Apr 15 02:49:39 2018 BST.